This agent used for clinical depression probably is not viable for use as a specific GRK2 inhibitor but is a great starting point for chemistry to develop novel GRK2 inhibitors that can be used eventually for cardiovascular disorders. This evidence concerns the gene GRK2 and depressive disorder.